Recombinant Anti-TCR(Vβ 8 ) × Anti-M2 Bispecific Antibody (TandAb) is a bispecific fusion protein with four binding sites, two of which bind to antigens of one kind of cells and the other two to the other kind of cells. This BsAb can retarget of Tcells to virus-infected cells. It was designed for the treatment of Inﬂuenza virus infection.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Please click here for more details about the introduction to mechanism of action, clinical projects and approved drugs of Vβ8 & M2 BsAb.